|
| miR-708-5p targets oncogenic prostaglandin E2 production to suppress a pro-tumorigenic phenotype in lung cancer cells |
|
https://doi.org/10.18632/oncotarget.27614
Nicholas J. Monteleone, Carol S. Lutz
|
| 2464-2483 |
|
| The role of miRNA-133b and its target gene SIRT1 in FAP-derived desmoid tumor |
|
https://doi.org/10.18632/oncotarget.27622
Maria Teresa Rotelli, Maria Grazia Refolo, Catia Lippolis, Aldo Cavallini, Arcangelo Picciariello, Domenico Piscitelli, Donato Francesco Altomare
|
| 2484-2492 |
|
| IQGAP1 control of centrosome function defines distinct variants of triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.27623
Mahasin A. Osman, William James Antonisamy, Evgeny Yakirevich
|
| 2493-2511 |
|
| Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking |
|
https://doi.org/10.18632/oncotarget.27637
Joshua T. Rose, Eliana Moskovitz, Joseph R. Boyd, Jonathan A. Gordon, Nicole A. Bouffard, Andrew J. Fritz, Anuradha Illendula, John H. Bushweller, Jane B. Lian, Janet L. Stein, Sayyed K. Zaidi, Gary S. Stein
|
| 2512-2530 |
|
| Potential use of lenvatinib for patients with unresectable hepatocellular carcinoma including after treatment with sorafenib: Real-world evidence and in vitro assessment via protein phosphorylation array |
|
https://doi.org/10.18632/oncotarget.27640
Tetsu Tomonari, Yasushi Sato, Hironori Tanaka, Takahiro Tanaka, Yasuteru Fujino, Yasuhiro Mitsui, Akihiro Hirao, Tatsuya Taniguchi, Koichi Okamoto, Masahiro Sogabe, Hiroshi Miyamoto, Naoki Muguruma, Harumi Kagiwada, Masashi Kitazawa, Kazuhiko Fukui, Katsuhisa Horimoto, Tetsuji Takayama
|
| 2531-2542 |
|
| IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells |
|
https://doi.org/10.18632/oncotarget.27650
Rehanna Mansor, Jeff Holly, Rachel Barker, Kalina Biernacka, Hanna Zielinska, Anthony Koupparis, Edward Rowe, Jon Oxley, Alex Sewell, Richard M. Martin, Athene Lane, Lucy Hackshaw-McGeagh, Claire Perks
|
| 2543-2559 |
|
| Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib |
|
https://doi.org/10.18632/oncotarget.27652
Alexis Genthon, Franck Emmanuel Nicolini, Françoise Huguet, Carole Colin-Gil, Marc Berger, Sandrine Saugues, Alexandre Janel, Sandrine Hayette, Pascale Cohny-Makhoul, Nadine Cadoux, Jean-Michel Cayuela, Lydia Campos, Denis Guyotat, Pascale Flandrin-Gresta
|
| 2560-2570 |
|
| Renal cell tumors convert natural killer cells to a proangiogenic phenotype |
|
https://doi.org/10.18632/oncotarget.27654
Yue Guan, Christopher B. Chambers, Taylor Tabatabai, Ha Hatley, Kristin R. Delfino, Kathy Robinson, Shaheen R. Alanee, Sophia Ran, Donald S. Torry, Andrew Wilber
|
| 2571-2585 |
|
| Correction: Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex |
|
https://doi.org/10.18632/oncotarget.27661
Cindy K. Miranti, Sara Moore, Yongeun Kim, Venkateshwar Reddy Chappeta, Kui Wu, Biswanath De, Vijay Gokhale, Laurence H. Hurley, Elsa M. Reyes-Reyes
|
| 2586-2586 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
